Azamak 100mg injection

About Azamak 100mg injection

Azamak 100mg Injection contains Azacitidine 100 mg, a chemotherapy medicine used in the treatment of specific blood cancers and bone marrow disorders, including Myelodysplastic Syndromes (MDS), Acute Myeloid Leukemia (AML), and Chronic Myelomonocytic Leukemia (CMML). It belongs to the class of hypomethylating agents that help restore normal bone marrow function by slowing the growth of abnormal blood cells. Azacitidine 100 mg is a commonly available vial strength used in oncology practice.

Manufactured under stringent quality standards, Azamak 100mg Injection is intended for administration by qualified healthcare professionals in hospitals and oncology centers. It should be used strictly under the supervision of an oncologist, with appropriate monitoring of blood counts and overall patient condition.

Product Details:

• Product Name: Azamak 100mg Injection
• Generic Name: Azacitidine Injection
• Strength: 100 mg
• Dosage Form: Lyophilized Powder for Injection
• Packaging: 1 Vial
• Route of Administration: Subcutaneous or Intravenous (as prescribed)
• Therapeutic Category: Anti-Cancer / Oncology
• Prescription Required: Yes